
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+15
Celemics is a Next Generation Sequencing (NGS) full solution provider based on target enrichment technology. We confidently offer custom target enrichment panels and high-quality pre-set panels, covering fields such as Inherited Diseases, Oncology, Immunology, and Pathogen Diagnostics. With 13 years of experience, we will provide the best solution for your Targeted Sequencing. [Products/Services] OncoRisk (Hereditary Cancer) | CancerScreen (Somatic Cancer) | Custom Target Enrichment Panel | Whole Exome Sequencing | Clinical Exome Sequencing | BRCA 1/2 | PharmacoScreen | Comprehensive Respiratory Virus | Agrigenomics
Ngs,target sequencing,whole exome panel,somatic cancer panel,clinical exome panel,customized ngs panel,target enrichment panel,ngs panel,bioinformatics,bioinformatics analysis,agrigenomics,liquid biopsy,cancer research,oncology diagnositcs,inherited diseases,virus research,ngs target enrichment panel,ngs reagents,ngs probe design,and clinical ngs
Celemics, inc operates in the Biotechnology research industry.
Celemics, inc's revenue is 1m - 10m
Celemics, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.